GenMont Biotech Incorporation (TPE:3164)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
17.75
+0.05 (0.28%)
At close: Feb 11, 2026
Market Cap1.53B -9.3%
Revenue (ttm)391.48M +6.2%
Net Income34.49M -35.1%
EPS0.39 -36.5%
Shares Out86.01M
PE Ratio45.52
Forward PEn/a
Dividend0.80 (4.52%)
Ex-Dividend DateMar 27, 2025
Volume62,623
Average Volume95,527
Open17.60
Previous Close17.70
Day's Range17.50 - 17.75
52-Week Range17.20 - 23.35
Beta0.21
RSI39.18
Earnings DateMar 13, 2026

About TPE:3164

GenMont Biotech Incorporation engages in the research and development, manufacture, and sale of various probiotic health products in Taiwan. It offers OEM and ODM services, including functional probiotic raw materials, capsules, powder, tablets, and liquid products. The company was founded in 2000 and is based in Tainan City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 3164
Full Company Profile

Financial Performance

In 2024, TPE:3164's revenue was 385.37 million, an increase of 21.18% compared to the previous year's 318.02 million. Earnings were 57.25 million, an increase of 73.54%.

Financial Statements